A short term cost-effectiveness model for oral antidiabetic medicines in Europe.
MacKeigan
L D
LD
Faculty of Pharmacy, University of Toronto, Canada.
D000284:Administration, Oral; D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000191:economics; D005060:Europe; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000191:economics*; D018803:Models, Economic
D007004:Hypoglycemic Agents